This cohort study of 901 patients with confirmed COVID-19 found that elevated serum interleukin-6 (IL-6) levels strongly correlate with disease severity and mortality. Critical cases had significantly higher IL-6 concentrations (median 21.55 pg/ml) than severe or common cases (P < 0.001), and IL-6 levels above 37.65 pg/ml predicted in-hospital mortality
